Filing Flows

Filing Flows › Cardlytics (CDLX) › Next earnings date

Cardlytics (CDLX) earnings: beat the estimate

Cardlytics (CDLX) reported on Nov 5, 2026 and beat the EPS estimate: −$1.03 against −$1.04 (+1.0%). Revenue was $32.9M for Q3 2026, -30% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+1.0% vs estimate
Beat rate100%

The last report

Cardlytics reported revenue of $32.9M for the third quarter 2026 (-30% Y/Y), net loss $8.9M: Engagement based pricing $21.7M, Served based pricing $10.1M, Other Revenue(1) $1.1M. How it makes money → · Every quarter →

Cardlytics: EPS against the estimate, last 5 reportsCardlytics: EPS against the estimate, last 5 reportsEstimateReported−$1.50−$0.70Nov 25−$0.70$0.30Mar 26−$2.13−$1.10May 26−$1.35−$0.81Aug 26−$1.04−$1.03Nov 26
Latest (Nov 26): Estimate −$1.04, Reported −$1.03.

Cardlytics' latest quarter

Cardlytics, Q3 2026: revenue $32.9M (-30% year over year), operating margin -16.5%, net loss $8.9M, operating cash flow −$5.9M. The chart follows the revenue to costs, profit and cash.

Questions

Did Cardlytics beat earnings?

Cardlytics (CDLX) reported on Nov 5, 2026 and beat the EPS estimate: −$1.03 against −$1.04 (+1.0%).

When does CDLX report earnings?

The next date is not set yet.

Does Cardlytics usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.